Kevin D. Brandt
2023 - Xtant Medical Holdings
In 2023, Kevin D. Brandt earned a total compensation of $947.4K as Chief Commercial Officer at Xtant Medical Holdings, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,827 |
|---|---|
| Option Awards | $144,743 |
| Salary | $415,000 |
| Stock Awards | $144,599 |
| Other | $13,200 |
| Total | $947,369 |
Brandt received $415K in salary, accounting for 44% of the total pay in 2023.
Brandt also received $229.8K in non-equity incentive plan, $144.7K in option awards, $144.6K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Kevin D. Brandt's compensation ranked 1,277th out of 3,006 executives tracked by ExecPay. In other words, Brandt earned more than 57.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,277 out of 3,006 | 58th |
Division Manufacturing | 762 out of 1,650 | 54th |
Major group Chemicals And Allied Products | 511 out of 918 | 44th |
Industry group Drugs | 499 out of 881 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 142 out of 213 | 33rd |
Source: SEC filing on June 10, 2024.
Brandt's colleagues
We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2023.
News
Xtant Medical Holdings CEO Sean Browne's 2023 pay jumps 61% to $1.7M
June 10, 2024
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021
Xtant Medical Holdings CEO Carl O'Connell's 2018 pay jumps 224% to $1.8M
September 20, 2019